John Gill

Vice President of Cell Line Development

John Gill is Abzena’s Scientific Leader and Vice President of Cell Line Development. John has over 30 years in the biopharmaceutical industry. He brings a wealth of scientific expertise, having previously worked at Gilead Sciences and Samsung Biologics.

John has specialized knowledge in stable cell line development platforms, cell banking, and upstream CDMO tech transfer.

Contact Our Expert

What is your cell line development challenge? Ask our expert today. We are ready to help.